beta
UNCY
Unicycive Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
unicycive therapeutics is passionate about treating kidney diseases with significant unmet medical needs.
Market Cap: 53.2 Million
Primary Exchange: NASDAQ
Website: unicycive.com
Shares Outstanding: 34.8 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.2173754168557048
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Ethical Flags
Longest drawdown: 262 trading days
From: 2023-03-10 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|